Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

Similar pages

• Trial
  Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment

  Shares Vididencel, Mendus and the tag pipeline.

• Trial
  Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia

  Shares Vididencel, Mendus and the tag pipeline.

• Trial
  Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia

  Shares Vididencel, Mendus and the tag pipeline.

• Trial
  Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma

  Shares Mendus and the tag pipeline.

• Trial
  Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)

  Shares Mendus and the tag pipeline.

• Trial
  A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors

  Shares Mendus and the tag pipeline.

• Trial
  A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer

  Shares Mendus and the tag pipeline.

• Trial
  A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

  Shares Chronic myeloid leukaemia (CML) and the tag pipeline.